Can we predict who gets severe COVID? luxembourg study seeks answers

NCT ID NCT04380987

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study followed 1,366 adults in Luxembourg who tested positive for COVID-19. Researchers tracked symptoms and took blood, swab, and stool samples to identify factors linked to severe disease. The goal was to better predict patient outcomes and improve care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors predict which COVID-19 patients are at risk of severe illness, enabling earlier and more targeted care.

What could go wrong

This is an observational study, not a treatment trial, so it cannot directly improve outcomes. The findings may not apply to other populations or virus variants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Luxembourg Institute of Health

    Luxembourg, Luxembourg